A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria
B. Burton*, M. Grant, A. Feigenbaum, R. Singh, R. Hendren, K. Siriwardena, J. Phillips, A. Sanchez-Valle, S. Waisbren, J. Gillis, S. Prasad, M. Merilainen, W. Lang, C. Zhang, S. Yu, S. Stahl
Dive into the research topics of 'A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria'. Together they form a unique fingerprint.